Dr. Mudhasir Ahmad

Dr. Mudhasir Ahmad

Verified
Senior Consultant
  • Medical Oncologist
MBBS, MD, DNB
Experience
18 yrs
AboutEducationSimilar doctorsFAQ

About Dr. Mudhasir Ahmad

  • Dr. Mudhasir Ahmad is a renowned Medical Oncologist with experience of more than 14 years
  • He has expertise in the treatment of Immunotherapy, Targeted therapy, and genetic mutation-based therapy, and cancers of the breast, gynecological (ovarian, cervix, uterine), lung, gastrointestinal, head and neck, lymphomas, myeloma, molecular therapy, endocrine therapy and
    advanced chemotherapy.
  • He is an active member of the American Society of medical oncology, European Society of Medical Oncology, Medical oncologists federation of A P, India, International Association for the Study of Lung Cancer, Indian society of medical and pediatric oncology and Delhi Oncology Forum.
  • He has received the Indian Council of Medical Research (ICMR) grant for a research presentation in Barcelona, Spain.
  • Dr. Ahmad has several publications in international as well as national journals.

 

  • VerifiedMBBS
  • VerifiedMD
  • VerifiedDNB

Papers Published

  • Hospital-based observational study on the tolerability, and efficacy of two Gemcitabine Oxaliplatin regimens Abstract. Annals of Oncology 24 (4): iv38–iv121, 2013
+ Read More
  • Hypercvad+Bortezomib Is a Well Tolerated Salvage Regimen for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia. Blood (ASH- American Society of Hematology- Annual Meeting Abstracts) 2010 116: Abstract 4345.
  • High Sensitivity C- Reactive Protein in the Male Patients with Angina with Normal Coronary Arteries. IJHSR. 2014; 4(4): 69-79
  • An Unusual Case of Refractory Seizure Disorder; An Insight into the Cause of Delayed Presentation of Functional Insulinoma. Austral - Asian Journal of Cancer ISSN-0972-2556, Vol. 13, No. 2, April 2014
  • Pulmonary artery thrombosis mimicking disease progression in metastatic renal cell carcinoma while on sunitinib. Published in Indian Journal of cancer in Jan-Mar, 2016, and a poster presentation in 31st ICON CONFERENCE Bhopal, MP, India. September 12, 2014. DOI: 10.4103/0019-509X.180852
  • Posterior reversible encephalopathy syndrome, the most uncommon adverse effect of one the commonest chemotherapy regimens, FOLFOX. Apollo Medicine March 2015. Published by Elsevier. Apollo medicine 12 (2015) 54-5 6
  • Infections in Hematopoietic Stem Cell Transplantation Recipients in the Pre-Engraftment Period. Global Journal of Hematology and Blood Transfusion, 09 January 2015. ISSN (online): 2408-9877

Send Your Enquiry

Fill in your details and our medical experts will contact you within 24 hours.

By submitting I agree to the Terms of Use and Privacy Policy of Vaidam Health.

Want to consult the doctor?

Don't Ignore Your Health!

Other Top Medical Oncologist In Noida

Dr. Rakesh Ojha

Dr. Rakesh Ojha

Medical Oncologist
Fortis Hospital, Noida · Noida
21+ years of experience
Chat IconChat
Dr. Malay Nandy

Dr. Malay Nandy

5.0 (58 Ratings)
Medical Oncologist
Jaypee Hospital, Noida · Noida
34+ years of experience
Chat IconChat
Dr. Atul Sharma

Dr. Atul Sharma

Medical Oncologist
Jaypee Hospital, Noida · Noida
19+ years of experience
Chat IconChat

FAQ's About Dr. Mudhasir Ahmad

What is the specialty of Dr. Mudhasir Ahmad?

Dr. Mudhasir Ahmad specialty is Medical Oncologist

What is the experience of Dr. Mudhasir Ahmad?

Dr. Mudhasir Ahmad is Medical Oncologist with 18 years of experience.

Our Network

500+

Top Hospitals

10,000+

Doctors

50+

Cities

10+

Countries

Need Assistance?Chat